INTERMITTENT CLAUDICATION: A DOUBLE–BLIND CROSSOVER TRIAL OF PENTOXIFYLLINE

A. S. GALLUS, F. GLEADOW, P. DUPONT, J. WALSH, A. A. MORLEY, A. WENZEL, M. ALDERMAN, D. CHIVEHS

Research output: Contribution to journalArticlepeer-review

38 Citations (Scopus)

Abstract

Abstract: The influence of the xanthine derivative pentoxifylline (‘Trental’ or BL191; Hoechst–Roussel) on exercise tolerance was measured in 38 subjects with stable, severe to moderately severe, intermittent claudication who completed a randomised, double–blind, placebo controlled, cross–over clinical trial. Patients received placebo tablets or 400 mg slow–release pentoxifylline tablets (‘Trental 400’) twice a day for one week, followed by three times daily for seven weeks, and then crossed over to receive the alternate preparation for another eight weeks. Claudication distance and walking distance were measured on a treadmill before starting treatment and again at four–week intervals during the trial. At the same times, red blood cell filterability, plasma fibrinogen concentration and blood viscosity, resting and post–ischemic calf muscle blood flow, and the resting and post–exercise ankle/brachial systolic pressure ratio were also measured. In this study, the observed effects of pentoxifylline treatment were no greater than those of placebo, even though serum levels of pentoxifylline and its hydroxy–metabolite were within the anticipated range. This was shown by a ‘therapeutic effect ratio’ of 0.98 for treadmill claudication distance and 0.96 for treadmill walking distance after within–patient analysis at the end of the cross–over (where a ratio of 1.0 means the test drug and placebo effects are identical). These ratios have 95% confidence limits of 0.72–1.34 and 0.74–1.25, respectively.

Original languageEnglish
Pages (from-to)402-409
Number of pages8
JournalAustralian and New Zealand Journal of Medicine
Volume15
Issue number4
DOIs
Publication statusPublished - Aug 1985
Externally publishedYes

Keywords

  • Claudication
  • cross–over trial.
  • pentoxifylline
  • red cell flexibility
  • treadmill testing

Fingerprint Dive into the research topics of 'INTERMITTENT CLAUDICATION: A DOUBLE–BLIND CROSSOVER TRIAL OF PENTOXIFYLLINE'. Together they form a unique fingerprint.

Cite this